Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Sherwin-Williams Company (The) Common Stock (SHW) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Sherwin-Williams Company (The) Common StockTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Sherwin-Williams Company (The) Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? Sherwin-Williams Company (The) Common Stock trades at $326.76 (market cap $78.68B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Sherwin-Williams Company (The) Common Stock is far larger — about 43.7× Vir Biotechnology Inc. Common Stock's market cap, and Sherwin-Williams Company (The) Common Stock pays a 0.99% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals.

SHWVIR
Market Cap
$78.68B$1.80B
Volume
1,245,3241,782,836
Sector
Basic MaterialsHealth
52-Week High
$372.60$11.78
52-Week Low
$293.00$5.12
Enterprise Value
$92.60B$1.36B
Dividend Yield
0.99%—
Typical Hold Time
—0 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Sherwin-Williams Company (The) Common Stock

Sherwin-Williams (SHW) trades at $324.10, up 1.21% with strong earnings momentum after beating estimates for three consecutive quarters. The stock shows neutral technical signals but maintains robust fundamentals with 65.12% ROE and expanding manufacturing capacity. Recent facility expansions in Statesville enhance production capabilities, positioning the company for continued market share gains.

Outlook remains positive with analyst consensus at Buy (57.9%) and $383.64 price target, though high valuation multiples (P/E 29.9) and competitive pressures present risks. Earnings growth and strategic investments support upside potential, while margin compression and economic sensitivity warrant monitoring.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SHW

No sentiment data available yet.

VIR
51% Buy49% Sell
Avg holding period · 0 Days

About Sherwin-Williams Company (The) Common Stock

The Sherwin-Williams Company manufactures, develops, and distributes paints, coatings, and related products through three segments: Paint Stores Group, operating more than 4,900 company-owned stores selling Sherwin-Williams-branded products; Consumer Brands Group, selling brands such as Valspar, Dutch Boy, Krylon, and Minwax through mass merchandisers and home centers; and Performance Coatings Group, supplying industrial, construction, and transportation coatings in more than 120 countries.

Read more on SHW →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →